cardiac MRI
cardiac MRI is an intervention with 90 clinical trials. Currently 24 active trials ongoing. Historical success rate of 92.5%.
Success Metrics
Based on 37 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
4
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.4%
37 of 46 finished
19.6%
9 ended early
24
trials recruiting
90
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
RELIEVE METAB Study
A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer
Multimodality Evaluation of Left Ventricular Remodeling In Mitral Regurgitation: A Pilot Study
Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
Clinical Trials (90)
RELIEVE METAB Study
A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer
Multimodality Evaluation of Left Ventricular Remodeling In Mitral Regurgitation: A Pilot Study
Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
Prospective Evaluation of the Biomechanical Properties of the Thoracic Aorta Coupling Magnetic Resonance Imaging and In-vitro Elasticity Tests in Patients With Ascending Aortic Aneurysm
Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy
Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance
Cardiovascular Magnetic Resonance Prognosticators in Pediatric Oncology Patients With Sepsis
CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study
MRI Assessment of Patient Suitability for Cardiac Resynchronization Therapy (CRT)
Natural History of Duchenne Muscular Dystrophy Cardiomyopathy (DMD-CMP)
Early Detection of Cardiotoxicity From Systemic and Radiation Therapy in Breast Cancer Patients
Understanding and Predicting Breast Cancer Events After Treatment
Circulating RNAs in Acute Congestive Heart Failure
Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity
CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma
Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction
Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease Biomarkers
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 90